drugset / Trial / NCT05615012
A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Participants
Non-randomizedSequentialOpen-labelTreatment
Summary
The aim of this study is to assess the effect of coadministration of multiple oral doses of BMS-986322 with rosuvastatin, metformin, and methotrexate in healthy participants.
Timeline
- Start
- 2022-11-11
- Primary completion
- 2023-12-13
- Completion
- 2023-12-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LOMECITINIB | Small molecule | — | — |
| Subject | Metformin | Small molecule | — | — |
| Subject | Methotrexate | Small molecule | — | — |
| Subject | Rosuvastatin | Small molecule | — | — |
| Background | Leucovorin | Small molecule | — | — |
Indications
No indication recorded.